A Survey of the Prevalence and Impact of Reporting Guideline Endorsement in Pathology Journals
A Survey of the Prevalence and Impact of Reporting Guideline Endorsement in Pathology Journals
复制标题
DOI：
10.1093/ajcp/aqx080
复制
发表时间：
2017-10-01
影响因子：
3.5
通讯作者：
Schmidt, Robert L.
中科院分区：
文献类型：
--
作者：
Caron, Justin E.;March, Jordon K.;Schmidt, Robert L.
Objectives: To determine the prevalence of reporting guideline endorsement in pathology journals and to estimate the impact of guideline endorsement.Methods: We compared the quality of reporting in two sets of studies: (1) studies published in journals that explicitly mentioned a guideline vs studies published in journals that did not and (2) studies that cited a guideline vs studies that did not. The quality of reporting in prognostic biomarker studies was assessed using the REporting recommendations for tumor MARKer prognostic studies (REMARK) guideline.Results: We found that six (10%) of the 59 leading pathology journals explicitly mention reporting guidelines in the instructions to authors. Only one journal required authors to submit a checklist. There was significant variation in the rate at which various REMARK items were reported (P
